drugset / Trial / NCT00620074

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074

Phase 4 Terminated 6 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will test the effectiveness and the safety of giving two antifungal agents (voriconazole and anidulafungin) together to treat invasive aspergillosis in patients who are unable to tolerate polyene therapy.

Timeline

Start
2008-08
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Anidulafungin Other / unclassified 100 mg
Subject Voriconazole Small molecule 4 mg/kg Intravenous
Subject Voriconazole Small molecule 300 mg Intravenous